Kamada Reports Preliminary Results from Phase II/III Pivotal Trial in Europe and Canada of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency
Emphysema, News
Ness Ziona, Israel, based plasma-derived protein therapeutics company Kamada Ltd. this week announced preliminary top-line results from its recently completed Phase II/III pivotal clinical trial in Europe and Canada of ... Read more